Opinion: Listen: Polio is back in the U.S. Two physicians offer ways to fight its spread
Polio has exploded back into Americans’ consciousness after being out of the spotlight in the…
Category: Biotech
To stem overdoses, Canada is offering safer opioids. Advocates want the U.S. to do the same
TORONTO — The Finks, married just a month earlier, sat down for their appointment, Kim…
Epic hits a crossroads, judge rules on UnitedHealth’s Change bid, & Meta faces health data pressure
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
.jpg)
STATUS List Spotlight: Leading JAMA Through Turmoil ft. Kirsten Bibbins-Domingo
Editor’s note: A livestream of the conversation will be embedded below at 2:00 pm. This February,…
STAT+: Pharmalittle: Haleon argues it’s not liable for any Zantac claims; FDA steps up surprise inspections in India
Top of the morning to you, and a fine one it is. Crystal clear blue…
Opinion: Hospital financing in black and white
During our training as doctors, we have rotated through safety-net hospitals, elite academic medical centers,…
Poxviruses, outbreaks, and Ebola: A Q&A with a retiring CDC expert on bad bugs
In the last week of August, one of the world’s foremost poxvirus experts retired from…
Opinion: Preventive services can improve Americans’ health, but they are now on trial
Twelve years after the Affordable Care Act was enacted, it appears to be here to…
A new study asks: Are we harming blood donors by taking blood from them?
One question has plagued the field of blood donation for as long as there have…
.jpg)
Coors, Mondelez, and other big food companies want to sell CBD-filled food and drinks. The FDA is staunchly opposed
WASHINGTON — Major food makers are ready to cash in on selling CBD-filled foods and…
STAT+: New CRISPR startup, drawing big-name backers, seeks to fix diseases caused by large DNA errors
A new CRISPR startup — backed by some big names in venture capital — is…
STAT+: Minimal compliance, or meaningful change? Epic faces a crossroads as new rules put pressure on health data sharing
In the business of selling record-keeping software to hospitals, Epic Systems is breaking away from…
STAT+: Ruling against DOJ allows UnitedHealth bid for Change Healthcare to proceed
A federal judge on Monday shot down the U.S. Justice Department’s legal challenge to UnitedHealth…
Is the Covid-19 pandemic over? The answer is more art than science
Is the Covid-19 pandemic over? President Biden told Scott Pelley of “60 Minutes” it was….
House Democrat presses bill to encourage more diversity in clinical trials run by NIH
Rep. Robin Kelly admits that the word “diversity” has scared some of her Republican colleagues…
Meta faces mounting questions from Congress on health data privacy as hospitals remove Facebook tracker
Meta is facing mounting questions about its access to sensitive medical data following a Markup…
A teaching hospital payout, Humana flirts with Wall Street, and new dialysis incentives
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Pfizer accused of running a fellowship program that discriminates on racial grounds
In a move reflecting simmering controversy over diversity and equity, Pfizer has been accused of…
STAT+: Pharmalittle: Advances in treating the sickest Covid patients have stalled; Moderna aids WHO effort to develop mRNA coronavirus shots
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Patients for Affordable Drugs taps new leader
WASHINGTON — One of Washington’s most prominent drug pricing patient groups is tapping an advocate who…
‘I’m deeply concerned’: Francis Collins on trust in science, how Covid communications failed, and his current obsession
Former NIH director and current White House science adviser Francis Collins told a group of…
Opinion: FDA and USDA need to get on board with the CDC about reducing antibiotic use in raising animals for food
The overuse of antibiotics and other antimicrobials in raising farm animals for food may not…
STAT+: Have researchers hit a wall in the hunt for severe Covid drugs?
It seemed interminably slow then, what with all the haze and fear of fresh plague,…
Opinion: Surgery needs a new pay model, free from incentives to do more procedures
How will my surgeon get paid? That’s a question few people ask as they think…
Medicare is using one of its biggest hammers to try to fix the dialysis system: how providers are paid
Chronic kidney disease, already a problem affecting millions of Americans, is only expected to become…
STAT+: Pharmalittle: CRISPR-based drug shows promise in preliminary study; FDA user fee program prompts fresh worries over conflicts
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Intellia says CRISPR treatment safely corrects DNA of six patients with rare disease
Intellia Therapeutics said Friday the first six patients to receive its CRISPR-based treatment for a…
Opinion: The White House has a major chance to improve coordination of federal nutrition efforts
At the end of September, the White House will host a Conference on Hunger, Nutrition…
At a fashion show for people with spinal muscular atrophy, models take back their own stories
NEW YORK — The scene: a fashion show on Fifth Avenue. The catwalk was not…
STAT+: Humana appeases Wall Street with big projections of Medicare Advantage growth
Humana is targeting ambitious growth of its Medicare Advantage plans and primary care clinics over…
The meth crisis is worse than ever, but new treatments might be around the corner
When it comes to meth addiction, Thomas Robey has long been at a loss. As…
STAT+: Savvier buyers threaten mental health tech’s momentum
When the pandemic exposed long-festering problems around access to mental health care, many organizations started…
Listen: Pharma’s telehealth gold mine, the return of the biotech IPO, & a merger deferred
Is online prescribing a good idea? When is $2 billion not a lot of money?…
Pharma leans into telehealth, Flo’s anonymous mode arrives, and clever digital deals
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Borrowing CAR-T tool from cancer therapy, lupus patients go into remission
Rheumatology — the study of immune-system-driven diseases of the bones, joints, muscles, and in-betweens —…
STAT+: Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug
In a victory for Gilead Sciences, Brazilian antitrust authorities dismissed a complaint filed by several…
STAT+: Pharmalittle: Swiss authorities probe Novartis over patent used to block rivals; Medicare underserves older Americans with opioid use disorder
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Swiss authorities raid Novartis offices seeking info on patents used to block rivals
The Swiss Competition Commission has begun an investigation into Novartis over the possible unlawful use…
STAT+: Lawmaker requests investigation into HCA over billing practices
WASHINGTON — A Democratic House lawmaker with oversight authority is calling for an investigation into the…
Opinion: 6 tactics to make artificial intelligence work on the frontlines
Artificial intelligence is a transformative tool in the workplace — except when it isn’t. For…
‘How do we support each other?’: A physician and ethicist on the difficult decisions doctors now face in abortion care
As new abortion bans are enacted around the country, physicians working with pregnant patients are…
Opinion: Congress needs to preserve seniors’ access to pharmacist care
Covid-19 demonstrated how quickly the United States can mobilize to produce and distribute new tests,…
These 3 startups are trying to improve diversity in clinical trials, a challenge experts say will take more than just tech
A host of health tech startups and companies are advertising their apps and platforms as…
Medicare provides insufficient access to opioid addiction treatment, report finds
Medicare is vastly underserving older Americans with opioid use disorder, with only 18% of enrollees…
Tell us about your experience with telehealth linked to pharma companies
Drug ads have long tried to influence patients’ medical choices, directing them to “ask your…
STAT+: Pharmalittle: Pharma pursues the ‘dream’ of online prescribing; EC chief under fire over Pfizer vaccine contract
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
U.S. to spend more than $2 billion to launch Biden’s biomanufacturing initiative
The federal government is pledging more than $2 billion to launch President Biden’s new national…
STAT+: Medical pioneers team up to launch new cell therapy biotech
Medical pioneers Carl June, Bruce Levine, and Drew Weissman have teamed up to launch a…
Daily multivitamins improved the brain function of seniors in a trial — but plenty of questions remain
While pharma companies struggle to show that cutting-edge therapies can treat, prevent, or slow Alzheimer’s…
Opinion: A challenge trial can streamline testing of hepatitis C vaccines
Trade-offs in medicine can be harsh, even when clearly necessary. Chemotherapy can save people from…